论文部分内容阅读
美国三大肿瘤协会:临床肿瘤协会、肿瘤研究协会和肿瘤研究院最近提出应对肿瘤的临床药物试验重新进行设计,建议研究前和研究中即对药物的个体化差异进行评价,以便尽快发现有效治疗药物。这项建议是基于2005年3月美国食品与药品监督管理(FDA)制定的个体化医疗指南得出的。
Three major oncology associations in the United States: The Clinical Oncology Association, the Oncology Research Institute and the Oncology Institute recently proposed a redesign of the clinical drug trial to address tumors, recommending that individualized differences be evaluated before and during the study to find effective treatments as soon as possible drug. This recommendation is based on a March 2003 personalized food guide developed by the U.S. Food and Drug Administration (FDA).